home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Serotonin And The Brain

 
  September, 20 2007 8:34
your information resource in human molecular genetics
 
     
Serotonin is used faster in the winter by people suffering from seasonal depression when compared with a control group, according to research published in Neuropsychopharmacology this month. The research also shows that serotonin usage returns to normal both where depression is treated effectively and during the summer months.

In depression, studies have found that the brain has too little of a neurotransmitter known as serotonin. However, why the brains of people with depression have low levels of serotonin is not known. Matthaus Williet and colleagues studied the primary way that the brain removes serotonin, known as the serotonin transporter, using an easily accessible model system: the blood platelets. The researchers tested this for a specific type of depression, known as seasonal depression; a depression that worsens in the winter and improves in the summer. This finding, if replicated, could help identify people at risk for depression and could lead to development of a new line of treatment.

Contact:

Matthaus Willeit (Medical University Vienna, Austria)

E-mail: matthaeus.willeit@medunivien.ac.at

© Neuropsychopharmacology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.